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Steroid-resistant nephrotic syndrome and congenital anomalies Congenital anomalies of the kidney and urinary tract
of kidneys: Evidence of locus on chromosome 13q. (CAKUT) are a major cause of renal dysfunction in child-
Background. Steroid-resistant nephrotic syndrome (SRNS) hood and span a wide range of urinary system malforma-
and congenital anomalies of kidney and urinary tract (CA-
tions, including ureteropelvic junction (UPJ) obstruction,KUT) are major causes of renal dysfunction in children. Al-
vesicoureteral reflux (VUR), hypoplastic or multicysticthough a few patients with 13q deletion have been previously
reported with renal anomalies, the association of SRNS with dysplastic kidneys, and bladder outlet obstruction [1–4].
13q has not been reported and critical regions associated with These anomalies often coexist (i.e., VUR can often be
CAKUT have not been identified. We present the results of seen in the contralateral side of individuals with ureteral
deletion mapping studies to identify the critical regions.
duplication, or renal dysplasia) [5, 6]. Many of theseMethods. Cytogenetic and deletion mapping studies were
malformations also show familial clustering with variableperformed on DNA obtained from peripheral blood of two
penetrance [2, 7–10].children with renal anomalies and interstitial deletion of 13q
as well as their parents. Twenty eight microsatellite markers Although the etiology of CAKUT is probably multi-
with a spacing of 1-8 Mb (1-3 cM) were utilized. factorial, it is likely that many of the CAKUT cases have
Results. The patients (both males, 5 and 10 years old) had a genetic cause. Recent studies have identified mutationsvarying severity of developmental delay and other neurologic
in the several genes that are associated with CAKUT indisorders. The renal involvement included hydronephrosis,
humans [2, 11–16]. Additionally, there is now growingureterocele, renal dysplasia, and mesangioproliferative SRNS.
Our studies imply existence of at least two critical regions in evidence different renal and urologic malformations may
the 13q area that are linked to CAKUT. The first is a 7 Mb even be caused by mutations in the same gene(s) [2].
region defined by markers D13S776 and D13S891 shared by Besides CAKUT, another common kidney disease [i.e.,both patients. The second is a much larger region extending
nephrotic syndrome (NS)/focal segmental glomerulo-at least 33 Mb above D13S776 seen in one patient with severe
sclerosis (FSGS)] is increasingly thought to have a ge-renal malformations and SRNS.
Conclusion. We report an association of chromosome 13q netic basis and lately several genes have been identified
with CAKUT as well as SRNS. Our studies suggest the pres- [17–22]. All of these studies point to genetic heterogene-
ence of more than one gene in this region that is likely to be ity of CAKUT and NS/FSGS, although none of the NS/
involved in renal development and function.
FSGS genes are associated with CAKUT. We identified
two children with 13q deletion who had a range of CA-
KUT with one child having steroid-resistant nephroticKey words: 13q deletion, CAKUT, steroid-resistant nephrotic syn-
drome, renal anomalies, ureteropelvic junction obstruction. syndrome (SRNS). Although cases of 13q deletion syn-
drome have been previously identified with renal malfor-Received for publication October 8, 2002
mations, its association with SRNS has not been reportedand in revised form December 11, 2002, and January 29, 2003
Accepted for publication February 28, 2003 and no information is available on the critical regions
on 13q associated with renal development [23]. We de- 2003 by the International Society of Nephrology
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scribe the results of cytogenetic and molecular genetic where 1.38 is the shape coefficient for a sphere and 1.01
is the variability coefficient, assuming a 10% coefficientstudies to identify the critical region(s) on 13q associated
of variation [24–26].with renal anomalies.
Cytogenetic studies
METHODS These were performed on peripheral blood lympho-
The study was approved by the Human Rights Com- cytes from the proband and the parents using standard
mittee of the Children’s Hospital of Pittsburgh (CHP) protocols as previously described [27]. Studies included
and informed consent was obtained from the parents of GTG banding and fluorescent in situ hybridization
the children described in the study. We identified two (FISH) using RB-1 and 13q34-qter specific (D13S327)
children with 13q deletion and peripheral blood was ob- probes in one patient.
tained for the genetic studies. One of the patients at-
Deletion mappingtended the clinics at CHP and the other patient was
Genomic DNA was extracted from peripheral bloodidentified through the Chromosomal Deletion Outreach
lymphocytes by proteinase K digestion and phenol-chlo-Organization (www.chromodisorder.org). The patients
roform extraction [22]. The two families were assessedwere investigated by various radiologic and biochemical
for deletion mapping at 13q by microsatellite analysis.tests, including ultrasonography, vesicocystourethrogra-
Twenty eight microsatellite markers spanning the 13qphy (VCUG), intravenous pyelography (IVP), computed
region were examined. Primer pairs were obtained com-tomography (CT), and magnetic resonance imaging (MRI).
mercially (Research Genetics, Huntsville, AL, USA).
Histologic and morphometric studies Microsatellite markers were analyzed after amplification
by polymerase chain reaction (PCR). The PCR reactionsLight microscopic, electron microscopic, and immuno-
were performed as described previously [28]. PCR prod-fluorescence studies were performed on the kidney tissue
ucts were diluted 1:1 with loading buffer [95% deionizedin case #1. For light microscopy, the kidney tissue was
formamide, 20 mmol/L ethylenediaminetetraacetic acidfixed in 10% neutral buffered formalin, embedded in
(EDTA), 0.025% xylene cyanol, and 0.025% bromophe-paraffin, cut at 3 m, and stained with hematoxylin and
nol blue] heat-denatured and eletrophoresed througheosin (H&E), periodic-acid Schiff (PAS), and trichrome
7% polyacrylamide gel containing 5.6 mol/L urea andstains. For electron microscopy studies, the tissue was
32% formamide for 3 hours at 55C. Gels were exposedfixed in 4% paraformaldehyde/0.5% glutaraldehyde, and
to x-ray films at 80C. Genotypes were scored visuallypostfixed in 1% osmium tetroxide and embedded in
and deletion was mapped by comparing the genotypesEpon-Araldite. Immunoglobulins (IgG, IgA, and IgM),
of parents with that of the probands. The markers usedC3, C4, C1q, fibrin, and albumin antibodies were used for
were D13S787, D13S1493, D13S894, D13S626, D13S784,direct immunofluorescence studies. For morphometric
D13S791, D13S889, D13S891, D13S318, D13S776,studies, images of light microscopy sections were ac-
D13S800, D13S265, D13S281, D13S167, D13S793,quired digitally using a Nikon Diaphot (Melville, NY,
D13S154, D13S1252, D13S159, D13S779, D13S1267,USA) inverted microscope, with a 40 objective lens,
D13S317, D13S174, D13S280, D13S1311, D13S796,
equipped with a Carl Zeiss CCD video camera (Thorn-
D13S286, D13S895, and D13S285.
wood, NY, USA) and a dedicated IBM-PC–compatible
computer (Dell, Round Rock, TX, USA) at a final mag-
RESULTSnification of 532 for a 72 dots per inch (dpi) resolution
image. The final image had a pixel value of 0.495 m Table 1 shows a summary of findings in the two chil-
and the whole image analysis system was calibrated with dren. Case #1 had the more severe involvement with
a slide micrometer (Fisher Scientific, Hanover Park, IL, CAKUT as well as SRNS. Both the children had other
USA). The glomerular tuft region for each glomerulus significant organ involvement, including developmental
delay.(N  6) was manually outlined (also shown in Fig. 3c)
and the glomerular area (GA) was calculated using Met-
Case #1amorph image analysis software program (Version 4.6r10,
This boy was diagnosed with 13q deletion soon afterUniversal Imaging Corporation, Downingtown, PA, USA).
birth and belonged to a large 53-member three-genera-The mean glomerular area (MGA) was calculated by
tion family with multiple members having rectourogeni-averaging the individual GA of each glomerular tuft. The
tal malformations (including omphalocele, exstrophy,mean glomerular volume was estimated by the Weibel-
hypospadias, and cryptorchidism) and dysplastic nevusGomez method by the formula:
syndrome. The child presented with mild intermittent
edema along with recurrent urinary tract infections at 3Mean glomerular volume 
1.38  (MGA)(3/2)
1.01 years of age in 1999. He also had hypospadias and poorly
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Table 1. Salient features of cases with 13q deletion
Case Current Age at
No. age years Gender diagnosis Karyotype Renal abnormalities Other abnormalities
1 5 Male At birth 46, XY, del Bilateral ureterocele, right hydro- Bifid scrotum, hypospadias retinoblastoma,
(13)(q12q22.3) nephrosis bladder diverticulum, communicating hydrocephalus, mitral
hyperechoic kidneys, steroid- stenosis, cardiomyopathy, developmental
resistant nephrotic syndrome delay, cleft soft palate, constipation,
hypoplastic nails
2 10 Male 1 year 46, XY, del Right hydronephrosis, ureteropelvic Mental retardation, hypotonia apraxia,
(13)(q21q32) junction obstruction, s/p pyeloplasty seizure, moderate bilateral hearing loss,
excessive drooling, incontinence
Fig. 1. Clinical features of case #1 showing
(a ) hypoplastic nails, (b ) bifid scrotum and
hypospadias, and (c ) midfacial hypoplasia.
developed bifid scrotum (Fig. 1). Urinalysis at 3 years years of age, more than 1 year after the onset of SRNS,
was considered to be normal. The hypertrophic and re-of age showed 3 to 4 proteinuria, with serum albumin
of 2.1 g/dL and hypercholesterolemia (251 mg/dL). He strictive cardiomyopathy progressed very rapidly and he
died at the age of 5 years 11 months due to complicationshad normal serum creatinine (0.2 mg /dL), blood urea
nitrogen (BUN) (7 mg/dL), and electrolytes (sodium, related to mitral valve stenosis, pulmonary edema, and
occult sepsis. A postmortem percutaneous kidney biopsy142 mEq/L; potassium, 3.7 mEq/L; chloride, 103 mEq/L).
A VCUG showed bilateral ureterocele with bladder di- was performed within 2 hours of death.
verticulum and no reflux (Fig. 2 a to c). A renal ultra-
Case #2sound showed bilateral hyperechoic hypoplastic kidneys
and right-sided hydronephrosis (Fig. 2 d and e). He re- This 10-year-old boy presented with developmental
delay and hypotonia at 1 year of age in Finland. Investi-sponded only partially to a prolonged course of steroids
(prednisone 2 mg/kg/day orally for 8 weeks) with im- gation performed at that stage showed right-sided hydro-
nephrosis on ultrasonography. An IVP and diuresis reno-provement in serum albumin (3.1 g/dL) but had no
change in proteinuria (3 to 4 during the whole 8-week gram suggested UPJ obstruction on the right side. A
right pyeloplasty was performed at 18 months of age.course). He, however, showed a dramatic response to
angiotensin-converting enzyme (ACE) inhibitor ther- There have been no urinary or abdominal symptoms
since then. Urinalysis at 8 years of age (in year 2000)apy. He responded completely to captopril therapy with
normalization of serum albumin (4.4 g/dL) and complete showed microscopic hematuria with three to five red
blood cells per high power field and no proteinuria.disappearance of proteinuria. Withdrawal of captopril
led to relapse and remission followed by reintroduction Other studies done at that time showed that BUN was
11 mg/dL, creatinine was 0.3 mg/dL, albumin was 4.6of captopril. However, prolonged captopril therapy was
associated with development of hyponatremia and he g/dL, sodium was 138 mEq/L, potassium was 3.9 mEq/L,
chloride was 101 mEq/L, and total carbon dioxide was 24was switched to losartan (Cozaar) therapy. He was main-
tained on low-dose losartan (6.25 mg/day orally) inter- mEq/L. Extrarenal involvement in this patient included
moderate bilateral hearing loss, apraxia, incontinence,mittently for 2 years. Extrarenal involvement in this child
included bilateral retinoblastoma, communicating hy- mental retardation, epilepsy, and excessive drooling.
drocephalus (on MRI), severe mental retardation, gas-
Histologic and morphometric studiestroesophageal reflux, severe constipation, hypoplastic
nails, and midfacial hypoplasia (Fig. 1). At approxi- The postmortem kidney biopsy in case #1 showed en-
larged glomeruli with dilated capillaries, expanded mes-mately 5 years of age he was found to have polyvalvular
heart disease, including mitral stenosis and a cardiomy- angial matrix, and increased mesangial cellularity. The
degree of mesangial matrix expansion and mesangialopathy, even though an echocardiogram performed at 4
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Fig. 2. Radiographic findings in case #1. Retrograde cystography showing a large right-sided and a smaller left-sided ureterocele seen as filling
defects on initial filling phase (a ), and voiding phase of the study (b ). Post void film in (c ) shows a bladder diverticulum on the right side. Renal
ultrasound findings of the right kidney in the same patient showing a hyperechoic kidney with poor corticomedullary differentiation and minimal
hydronephrosis in transverse (d ) and sagittal (e ) views.
cellularity varied between glomeruli (Fig. 3 a to d). Other metaphase cells. FISH with retinoblastoma gene probe
(RB-1) which maps to 13q14 showed positive signalsglomerular changes included prominence of juxtaglo-
merular areas, hypertrophy of some visceral epithelial in only one chromosome 13. FISH with the 13q32-q33
specific (D13S585) and 13q34-qter specific (D13S327)cells, as well as segmental parahilar sclerosis in two glo-
meruli (Fig. 3 b and c). Patchy interstitial fibrosis and probes showed positive signals in both 13 chromosomes,
thus confirming the above findings. No cytogenetic ab-tubular atrophy were also seen (Fig. 3d). Immunofluo-
rescence studies revealed segmental, granular deposits of normalities were found in the parents. Cytogenetic stud-
ies in case #2 showed interstitial deletion of 13q [i.e.,C3 and IgM in mesangial areas (Fig. 3 e and f). Electron
microscopy studies showed expansion of mesangial ma- 46, XY, del(13)(q21q32)]. No cytogenetic abnormalities
were found in the parents of case #2.trix, increased numbers of mesangial cells, and a few
small electron dense deposits in mesangium (Fig. 3 g and
Deletion mapping studiesh). Although hypertrophy of visceral epithelial cells and
microvillous transformation were observed, the foot pro- Table 2 shows the details of deletion mapping studies.
cess fusion was focal and mild (Fig. 3i). Morphometric The PCR product sizes for each marker pair and the
studies were limited as only six glomeruli were present in visually ascertained allele for each marker and each indi-
the tissue submitted for light microscopy. The glomerular vidual (arbitrarily labeled alphabetically) are shown. The
tuft area ranged from 1.1  105 m2 to 1.9  105 m2 physical distances for each marker are based on the June
and the mean glomerular volume was calculated to be 2002 assembly of the human genome available through
3  106 m3. University of California Santa Cruz (UCSC) genome
browser (http://genome.ucsc.edu). The genetic distances
Cytogenetic studies for the markers were derived from the genetic location
database (LDB) (fttp://cedar.genetics.soton.ac.uk/pub/Karyotyping studies with GTG banding in case #1
showed interstitial 13q deletion [i.e., 46, XY, del(13) chrom13/map.html). Deletion mapping in case #1 showed
a large deletion extending at least from 32 Mb to 73 Mb(q12q22.3)] (Fig. 4). FISH studies were performed in 10
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Fig. 3. Renal biopsy in case #1. (a ) Light microscopy shows glomerulus with dilated capillaries and mild mesangial hypercellularity [periodic-acid
Schiff (PAS) 200]. (b ) Light microscopy shows glomerulus with perihilar sclerosis (arrows) (PAS 200). (c ) Light microscopy shows enlarged
glomerulus with mesangial hypercellularity and matrix expansion as well as perihilar sclerosis (arrow) [hematoxylin and eosin (H&E) 400]. The
outlined tuft area was used to calculate glomerular area and volume. (d ) Light microscopy of an area of tubular atrophy and a glomerulus with
expanded mesangium. (e ) Immunofluorescence microscopy shows segmental C3 deposits in mesangial areas. (f ) Immunofluorescence segmental
immunoglobulin M (IgM) deposits in mesangial areas. (g ) Electron microscopy shows increased mesangial cellularity (6200). (h ) Electron
microscopy shows few small electron dense deposits in mesangium (arrow) (34,000). (i ) Electron microscopy shows visceral epithelial cells
(podocytes) with microvillous transformation and focal foot process fusion (6200).
(25 cM to 73 cM). Deletion mapping in case #2 showed focused on identification of genes responsible for these
a smaller deletion extending at least from 65 Mb to 81 syndromes [2, 4]. Over the last two decades occasional
Mb (63 cM to 85 cM). The deleted region in both the cases of 13q deletion syndrome have been reported with
cases is shown in bold. CAKUT, but no information is available on the critical
Our studies imply existence of at least two critical regions associated with renal development [23, 29, 30].
regions in the 13q area that are involved in the develop- We report association of chromosome 13q with SRNS
ment of CAKUT and SRNS. The first is a 7 Mb region as well as CAKUT and provide evidence for location of
defined by markers D13S776 and D13S891 and shared at least two genes in this region that are likely to be
by both patients. The second is a much larger region responsible for renal development in utero and mainte-
extending at least 33 Mb above D13S776 seen in case #1. nance of glomerular permselectivity ex utero. Our stud-
ies suggest existence of two critical regions on 13q. The
DISCUSSION first is an at least 7 Mb region defined by markers
D13S776 and D13S891 shared by both patients that isSRNS and CAKUT are major causes for morbidity in
pediatric age group and lately a number of studies have likely linked to CAKUT. The second is a much larger
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Fig. 4. Karyotype details of case #1. (A ) Karyotype shows deleted 13q region (arrow). (B ) The details of the deleted region in two of the cultured
cells along with an ideogram of the region. (C ) A schematic diagram of the deleted region of the chromosome common to both cases with some
of the genes in the region displayed as symbols.
Table 2. Deletion mapping data for cases #1 and 2 and their parents
Annealing
Position Position PCR product temperature Case 1 Case 1 Case 2 Case 2
Marker Kb cM size bp used C Case 1 father mother Case 2 father mother
D13S787 22360 7 251 56 AB AB AA BC BC BC
D13S1493 31995 25.8 250 57 BB BC AB AD BD AC
D13S894 36724 33 190 56 BB AB BB AB AB BB
D13S626 51310 56.77 339 55 B AC BB CD CD BD
D13S784 53073 57.06 195–196 55 C AB BC AA AA AA
D13S889 61530 60.43 294–295 55 B AC BC BC BB BC
D13S776 65395 67.58 142 55 D AC BD BB AB BC
D13S318 68543 65.23 284 51 B AD BC B AA BD
D13S800 71842 69.82 295–296 56 C AB BC D BB DD
D13S791 71842 72.57 293–294 58 D BC AD D AC BD
D13S891 72786 63.76 200 51 A BC AB AA AB AA
D13S317 80689 85.07 200 56 AB AC BD DD CD BD
D13S265 88733 86.56 293–294 58 NA NA NA BC BC BB
D13S281 92923 92.8 238 55 NA NA NA AC AC AA
D13S167 93035 92.6 184–192 55 NA NA NA CC CC CC
D13S154 94622 94.4 243–277 55 NA NA NA DE EE DG
D13S793 96311 95.75 262 57 AA AC AB AC AC AC
D13S1252 96897 96.1 194–238 62 NA NA NA AB BB AB
D13S159 97414 96.4 168–203 56 NA NA NA BB BC AB
D13S1267 99257 98.49 184–216 58 AC AB BC AB AB AB
D13S779 99864 98.64 191 52 NA NA NA AC CC AC
D13S174 101314 99.7 173–199 55 NA NA NA BD AB BD
D13S280 101907 100.14 138 55 NA NA NA AD CD AB
D13S1311 104552 102.13 141–149 62 NA NA NA BC CC BC
D13S286 105297 102.59 175–195 56 NA NA NA BC BB AC
D13S796 106249 104.5 167 56 CD AC BD CC BC CC
D13S895 107948 111.8 160 56 AC AB CD AB AB BB
D13S285 111405 113.58 92–106 56 NA NA NA BE BG EG
region, extending at least 33 Mb above D13S776, seen of steroids. Postmortem kidney biopsy provided further
insight into the pathology of 13q-associated SRNS. Thein case #1, and we propose that it contains a gene that
is linked to SRNS. biopsy revealed well-formed glomeruli and tubules as
well as absence of dysplastic features. The biopsy findingsTo our knowledge, chromosome 13q has not so far
been associated with SRNS phenotype and we report were compatible with mesangioproliferative glomeru-
lopathy with possible progression to FSGS. The meanthis association for the first time. Case #1 presented with
insidious-onset NS that was refractory to a long course glomerular volume estimate, although limited by the small
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number of glomeruli studied, also served to confirm the receptor 1 and is expressed in endothelial cells. This gene
is located above the retinoblastoma (Rb) gene locus atvisual impression of glomerular hypertrophy. The mean
13q14 [33]. Identification of additional 13q-linked SRNSglomerular volume of 3 106 m3 in case #1 was consid-
cases and narrowing of the region would, however, beerably higher (by almost three times) than seen in age-
required to allow any further discussion of positionalmatched minimal-change disease and normal controls in
candidate genes.our previous studies on these patient groups (abstract;
Although the 13q deletion in case #1 is fairly large,Vats A, et al, J Am Soc Nephrol 5:797, 1994). To put it
the deleted region shared by both patients is smaller,in perspective, in our studies on congenital NS patients,
extending at least 7 Mb (7 cM), and is likely to containthe mean glomerular volume was found to be 1.4  106
a CAKUT-associated gene. However, since the deletionm3 (range, 0.5 to 3.6  106 m3), and that of age-
can extend further telomeric to D13S891 in case #1, thismatched minimal-change NS patients was 0.7  106 m3
shared area can potentially be larger. It is interesting to(range, 0.4 to 0.9  106 m3) [26]. Mesangioproliferative
note that both the patients were males and had deletionsglomerulopathy and glomerulomegaly, however, are not
of paternal alleles. As only two patients are describedunique to 13q-associated SRNS and may be seen in sev-
in our studies, we cannot make any further generaliza-eral other proteinuric states that can be either idiopathic
tions on the significance of these observations; however,or secondary to a number of conditions, including con-
future studies may identify the role of gender and geno-genital heart disease [31]. In case #1, the biopsy was
mic imprinting, if any, in the causation of 13q-associatedtaken later in the course of the illness, when the patient
CAKUT. Recently, several genes responsible for CA-already had end-stage heart disease. Although it is possi-
KUT have been identified in humans and animal models,ble that his cardiac decompensation may have contrib-
but none lie on chromosome 13q [11–16]. An examina-uted to the renal pathology, the SRNS was most likely
tion of the 7 Mb minimal critical region, shared by thea primary condition as it preceded the onset of cardiomy-
two cases, reveals a number of characterized genes suchopathy by almost 2 years. Thus, the 13q-associated SRNS
as protocadherin 9 (PCDH9), the human homolog of Dro-is a nonminimal change process and can be associated
sophila dachshund gene (DACH), and basic transcriptionwith a mesangioproliferative and segmentally sclerosing
factor 3-like 1 (BTF3L1), as well as a number of computer-glomerulopathy.
predicted genes. Of these genes, DACH is a strong candi-Recently several genes, located on various chromo-
date gene as it is expressed in developing eyes, kidneys,somes (i.e., 19q13 [nephrin (NPHS1) and alpha actinin 4
ears, and limbs and interacts with the eyes absent gene(ACTN4)], and 1q25 [podocin (NPHS2)]) have been
(EYA), which is associated with branchio-oto-renal (BOR)associated with SRNS/FSGS [18–22, 32]. Also two genes
syndrome in humans [34]. Also, BTF3L1, a transcriptionon chromosome 11 [i.e., the Wilms tumor-1 (WT-1) and
factor-like gene whose function is unknown at present,another gene tentatively labeled FSGS2] have been
and PCDH9, an adhesion molecule, may be a good can-linked to SRNS/FSGS [14, 21]. Interestingly, WT-1, lo-
didate genes. One or more of these genes may need tocated at 11p13, is associated with a phenotype with some
be investigated upon completion of further gene localiza-similarities to the features seen in case #1 (i.e., diffuse
tion studies.mesangial sclerosis and SRNS as well as urologic malfor-
Finally, the CAKUT and SRNS-associated critical re-mations) [14]. SRNS is, thus, a genetically heterogeneous
gions we described lie significantly centromeric to 13qdisease [32], and our studies provide evidence for an-
regions reported in previous such associations (usuallyother SRNS-associated gene located in the 13q region.
around 13q32-q33), although at least one patient withInterestingly, there were several other family members
del(13)(q14.3q22) was reported with unilateral renalwith urogenital malformations on the maternal side of
agenesis [23, 29, 30, 35]. Indeed, in a series of 22 retino-the case #1 family. However the parental chromosomal
blastoma patients, with deletions in the proximal 13q
assessment, by karyotyping, was normal. We propose that
regions, no renal or urinary findings were reported [36].
the SRNS gene on 13q is extremely responsive to ACE In view of the silent and asymptomatic nature of many
inhibitors, and to angiotensin receptor blockade (ARB). renal diseases, our findings would suggest that a careful
Since the renin-angiotensin system manipulation, by assessment of renal function and structure in cases with
ACE inhibitors and/or ARB, is an important therapeutic 13q deletion is appropriate. Institution of such assess-
tool in the management of various proteinuric states, ment, including yearly urinalysis, may uncover additional
our studies may provide clues to location of gene(s) that patients with renal involvement and may aid gene local-
are important in mediating the renoprotective effects of ization studies in future.
these agents. The critical region for this gene is fairly
large (i.e., at least 33 Mb approximately), but contains
CONCLUSIONseveral interesting genes, including human proto-onco-
gene c-fms (FMS)-related tyrosine kinase-1 (FLT-1). We report association of interstitial deletion of 13q
with steroid-resistant proteinuria and CAKUT and pro-FLT-1 is also called vascular endothelial growth factor
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